Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 78,477Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dabrafenib Mesylate

Brand Name : TAFINLAR

Patent Number : 2723396

Filing Date : 2009-05-04

Strength per Unit : 50 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2029-05-04

Date Granted : 2013-09-10

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dabrafenib Mesylate

Brand Name : TAFINLAR

Patent Number : 2723396

Filing Date : 2009-05-04

Strength per Unit : 75 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2029-05-04

Date Granted : 2013-09-10

blank